Pilot Study of TQ Formula in Combination with Nivolumab and Ipilimumab in Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECAs)

Autor: A Mohamed, SL Asa, A Azmi, D Bajor, SH Tirumani, JE Selfridge, A Mahipal, LM Ocuin, J Winter, J Ammori, J Hardacre, R Hoehn, S Chakrabarti, K Rostocil, A Kaseb

Publikováno v: Endocrine Abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8f8d9d1f9247fff0660869c84d03cbe4
https://doi.org/10.1530/endoabs.89.t10

Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues

Autor: Jl Freeman, B.F.A.M. van der Laan, Sl Asa

Publikováno v: Thyroid, 5(1), 67-73. MARY ANN LIEBERT, INC

A number of growth factors have been implicated as stimuli of thyroid cell proliferation; overexpression of these growth factors and/or their receptors may play a role in the growth of thyroid tumors. To determine if immunohistochemical detection of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860fbd55cdea0e65c03a219a2bbc3c68
https://pubmed.ncbi.nlm.nih.gov/7787437

Role of Bispecific Antibodies in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs): Review of Literature.

Autor: Mohamed A; Division of Medical Oncology, Department of Medicine, University Hospitals, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Elhawi M; Department of Clinical Oncology, Ain Shams University Hospital, Cairo, Egypt., Trybula M; Division of Medical Oncology, Department of Medicine, University Hospitals, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Elshawy M; Department of Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA., Chakrabarti S; Division of Medical Oncology, Department of Medicine, University Hospitals, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Selfridge E; Division of Medical Oncology, Department of Medicine, University Hospitals, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Asa SL; Department of Pathology, University Hospitals, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA.

Publikováno v: Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2024 Dec 07; Vol. 18, pp. 11795549241285213. Date of Electronic Publication: 2024 Dec 07 (Print Publication: 2024).

Machine Vision-Detected Peritumoral Lymphocytic Aggregates Are Associated With Disease-Free Survival in Patients With Papillary Thyroid Carcinoma.

Autor: Monabbati S; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio., Fu P; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio., Asa SL; Department of Pathology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Pathak T; Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia., Willis JE; Department of Pathology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio., Shi Q; Department of Pathology, Emory University Hospital Midtown, Atlanta, Georgia., Madabhushi A; Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia; Atlanta Veterans Administration Medical Center, Atlanta, Georgia. Electronic address: anantm@emory.edu.

Publikováno v: Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2024 Dec; Vol. 104 (12), pp. 102168. Date of Electronic Publication: 2024 Nov 04.

Pancreatic and Ileal Neuroendocrine Tumors: Metastatic Disease or a Novel MEN Syndrome?

Autor: Asa SL; Departments of Pathology and Oncology, University Hospitals Cleveland, Case Western Reserve University, Cleveland, OH., Mohamed A

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2024 Nov 01; Vol. 48 (11), pp. 1417-1424. Date of Electronic Publication: 2024 Jul 22.